Clinical Efficacy and Safety of Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Diarrhea-predominant Irritable Bowel Syndrome Interventions: Drug: Trimebutine Maleate Tablets; Drug: Jingfang Granules Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting Conditions: Diarrhea-predominant Irritable Bowel...

Digital Phenotyping of Psychological Distress in Skin Cancer Patients

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Skin Cancer; Melanoma (Skin Cancer); Squamous Cell Carcinoma Head and Neck Cancer (HNSCC); Basal Cell Carcinoma of Skin Sponsors: West China Hospital Completed Conditions: Skin Cancer; Melanoma (Skin Cancer); Squamous Cell Carcinoma Head and Neck Cancer...

Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Type 1 Diabetes Interventions: Other: Intensive lifestyle modification (hypocaloric Mediterranean diet and promotion of physical activity); Dietary Supplement: Butyrate; Dietary Supplement: Intensive lifestyle modification + butyrate Sponsors: Fundación...

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease; Mucosal Ulcerations Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting Conditions: Trisomy 8 Mosaicism; Trisomy 8 Associated Autoinflammatory Disease;...

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

by palligoelme@gmail.com | Jul 6, 2026 | Clinical Trials

​ Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors: Minghui Pharmaceutical (Hangzhou) Ltd Not yet recruiting Conditions: Vitiligo Interventions: Drug: MH004 1.0% Ointment; Drug: MH004 Placebo Ointment Sponsors:...